IRIS Accounts Production v25.1.0.734 13252683 Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh132526832024-03-31132526832025-03-31132526832024-04-012025-03-31132526832023-03-31132526832023-04-012024-03-31132526832024-03-3113252683ns15:EnglandWales2024-04-012025-03-3113252683ns14:PoundSterling2024-04-012025-03-3113252683ns10:Director12024-04-012025-03-3113252683ns10:Director22024-04-012025-03-3113252683ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3113252683ns10:SmallEntities2024-04-012025-03-3113252683ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3113252683ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3113252683ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3113252683ns10:AbridgedAccounts2024-04-012025-03-3113252683ns10:CompanySecretary12024-04-012025-03-3113252683ns10:RegisteredOffice2024-04-012025-03-3113252683ns5:CurrentFinancialInstruments2025-03-3113252683ns5:CurrentFinancialInstruments2024-03-3113252683ns5:ShareCapital2025-03-3113252683ns5:ShareCapital2024-03-3113252683ns5:RetainedEarningsAccumulatedLosses2025-03-3113252683ns5:RetainedEarningsAccumulatedLosses2024-03-3113252683ns5:PlantMachinery2024-04-012025-03-31
REGISTERED NUMBER: 13252683 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 March 2025

for

Life Science Works Ltd

Life Science Works Ltd (Registered number: 13252683)






Contents of the Financial Statements
for the year ended 31 March 2025




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Life Science Works Ltd

Company Information
for the year ended 31 March 2025







DIRECTORS: Dr J F Burke
Mrs A Burke





SECRETARY:





REGISTERED OFFICE: 18 St. Cross Road
Winchester
Hampshire
SO23 9HX





REGISTERED NUMBER: 13252683 (England and Wales)





ACCOUNTANTS: Hatcher Hughes Limited
Cassidy House
Station Road
Chester
Cheshire
CH1 3DW

Life Science Works Ltd (Registered number: 13252683)

Abridged Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 1,516 3,439
Investments 5 14,626 10,000
16,142 13,439

CURRENT ASSETS
Debtors 1,056 25,293
Cash at bank 249,697 110,417
250,753 135,710
CREDITORS
Amounts falling due within one year 39,079 34,023
NET CURRENT ASSETS 211,674 101,687
TOTAL ASSETS LESS CURRENT
LIABILITIES

227,816

115,126

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 227,814 115,124
SHAREHOLDERS' FUNDS 227,816 115,126

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Life Science Works Ltd (Registered number: 13252683)

Abridged Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 March 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 April 2025 and were signed on its behalf by:




Dr J F Burke - Director



Mrs A Burke - Director


Life Science Works Ltd (Registered number: 13252683)

Notes to the Financial Statements
for the year ended 31 March 2025

1. STATUTORY INFORMATION

Life Science Works Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

Life Science Works Ltd (Registered number: 13252683)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2024 8,704
Additions 336
At 31 March 2025 9,040
DEPRECIATION
At 1 April 2024 5,265
Charge for year 2,259
At 31 March 2025 7,524
NET BOOK VALUE
At 31 March 2025 1,516
At 31 March 2024 3,439

5. FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:
Totals
£   
COST
At 1 April 2024 10,000
Additions 4,626
At 31 March 2025 14,626
NET BOOK VALUE
At 31 March 2025 14,626
At 31 March 2024 10,000